These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27105511)

  • 1. Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer.
    Xu P; Xu N; Guo K; Xu A; Takenaka F; Matsuura E; Liu C; Kumon H; Huang P
    Oncotarget; 2016 May; 7(22):33025-34. PubMed ID: 27105511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
    van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
    Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transrectal ultrasound for monitoring murine orthotopic prostate tumor.
    Kusaka N; Nasu Y; Arata R; Saika T; Tsushima T; Kraaij R; Bangma CH; Kumon H
    Prostate; 2001 May; 47(2):118-24. PubMed ID: 11340634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer.
    Xu N; Huang L; Li X; Watanabe M; Li C; Xu A; Liu C; Li Q; Araki M; Wada K; Nasu Y; Huang P
    Int J Biol Sci; 2019; 15(5):919-928. PubMed ID: 31182913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.
    Ellis L; Ku S; Li Q; Azabdaftari G; Seliski J; Olson B; Netherby CS; Tang DG; Abrams SI; Goodrich DW; Pili R
    Prostate; 2016 Sep; 76(13):1192-202. PubMed ID: 27225803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
    Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
    Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1 as a biomarker to predict therapeutic effect of low-frequency ultrasound combined with SonoVue on prostate cancer in nude mice model.
    Xu W; Nan S; Bai W; Shen E; Hu B
    Cancer Biomark; 2014; 14(4):279-86. PubMed ID: 24934371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.
    Burton DW; Geller J; Yang M; Jiang P; Barken I; Hastings RH; Hoffman RM; Deftos LJ
    Prostate; 2005 Feb; 62(3):275-81. PubMed ID: 15389781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantable Animal Studies and Whole-Body Optical Imaging in Prostate Carcinoma.
    van der Horst G; van der Mark M; Cheung H; van der Pluijm G
    Methods Mol Biol; 2018; 1786():81-102. PubMed ID: 29786788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT vs. bioluminescence: A comparison of imaging techniques for orthotopic prostate tumors in mice.
    Myers MS; Kosmacek EA; Chatterjee A; E Oberley-Deegan R
    PLoS One; 2022; 17(11):e0277239. PubMed ID: 36331948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminomethylphosphonic acid inhibits growth and metastasis of human prostate cancer in an orthotopic xenograft mouse model.
    Parajuli KR; Zhang Q; Liu S; You Z
    Oncotarget; 2016 Mar; 7(9):10616-26. PubMed ID: 26840261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
    Dong L; Zhang X; Ren J; Wu S; Yu T; Hou L; Fu L; Yi S; Yu C
    Cancer Biother Radiopharm; 2013 Jun; 28(5):391-7. PubMed ID: 23701419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.
    Xuan JW; Bygrave M; Valiyeva F; Moussa M; Izawa JI; Bauman GS; Klibanov A; Wang F; Greenberg NM; Fenster A
    Mol Imaging; 2009; 8(4):209-20. PubMed ID: 19728975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis.
    Black M; Barsoum IB; Truesdell P; Cotechini T; Macdonald-Goodfellow SK; Petroff M; Siemens DR; Koti M; Craig AW; Graham CH
    Oncotarget; 2016 Mar; 7(9):10557-67. PubMed ID: 26859684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.
    Saar M; Körbel C; Linxweiler J; Jung V; Kamradt J; Hasenfus A; Stöckle M; Unteregger G; Menger MD
    Prostate; 2015 Oct; 75(14):1526-37. PubMed ID: 26074274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rat model of metastatic spinal cord compression using human prostate adenocarcinoma: histopathological and functional analysis.
    Sarabia-Estrada R; Zadnik PL; Molina CA; Jimenez-Estrada I; Groves ML; Gokaslan ZL; Bydon A; Witham TF; Wolinsky JP; Sciubba DM
    Spine J; 2013 Nov; 13(11):1597-606. PubMed ID: 23810458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    Han JH; Park SY; Kim JB; Cho SD; Kim B; Kim BY; Kang MJ; Kim DJ; Park JH; Park JH
    Am J Reprod Immunol; 2013 Oct; 70(4):317-26. PubMed ID: 23790156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
    Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
    Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.